Dr. Rahman has practiced as an ABMGG-certified clinical geneticist for 17 years working with various genetic counselors in a pediatric, adult, prenatal, and cancer clinical settings. He has served in various education roles including lecturer and facilitator for genetics to first-year medical students, nursing students, pharmacy students, pediatric residents, and fellows. He has taught genetic counseling students in a clinical setting for several years and in a classroom setting from 2019 to the present. He previously served as the associate program director for pediatrics, as vice-chair of faculty development, and as division chief and department director for medical genetics in two institutions. He is also a faculty member of the ACGME-accredited medical genetics residency at UNMC. 

Dr. Yazmin Carrasco is a fierce Diversity Advocate and a scientist in the field of Chemical Biology. Dr. Carrasco completed her PhD training at UT southwestern in the field of Analytical Chemistry. She then joined the NIH-funded IRACDA postdoctoral program at UCSF, there she had the opportunity to train in pedagogy and teach at San Francisco State University , while also pursing research in Chemical  Biology  at UCSF.  After her four-year postdoc, she joined the team of SF BUILD (Building Infrastructure Leading to Diversity; an NIH funded program to enhance the diversity of the biomedical workforce). She was part of the BUILD initiative for 4 years. She is currently the Assistant Dean for Diversity and Inclusion at Weill Cornell Graduate School. 

Megan is a board certified senior genetic counselor with extensive experience in clinical cancer genetics. As the operational manager of Memorial Sloan Kettering Cancer Center’s Clinical Genetics Service, she communicates and implements administrative processes while acting as a liaison between the clinical, administrative, laboratory, and research teams at her institution. 

Shenela is the Director for Genetic Counseling at the Center for Neurogenetics at Weill Cornell Medicine, with over 6 years of experience in providing both clinical and academic support for the Center for Neurogenetics. Her experience as an educator both nationally and internationally has provided her with extensive experience in providing lectures, teaching and designing objective-specific talks. She has been an invited speaker for genetic counseling students, residents and medical students. As part of different accredited programs, she has been asked to design USMLE board type multiple choice exam questions, reflective of the learning objectives of her talks. 

Jennifer Leyton is a seasoned Wall Street business manager / chief of staff. In 2009, she left finance to devote time to family and philanthropic causes. Since then, she has proudly sat on boards that support medical research, patient support and strong communities. Additionally, Jennifer is a support group leader for spouses of those with Alzheimer’s Disease and speaks with medical students educating them about Huntington’s disease. Jennifer received a MBA from Rutgers University and a BS from Emory University.  

Dr. Offit is a medical oncologist with clinical and laboratory experience in cancer genetics. His  research focuses on defining genetic factors that cause an increased susceptibility to cancer. His research team identified the most common mutation associated with an increased risk of breast and ovarian cancer among individuals of Ashkenazi Jewish ancestry. Dr. Offit and his MSKCC colleagues have published the first prospective series describing the outcome of preventive ovarian surgery and screening in women at hereditary risk for breast and ovarian cancer. Ongoing research is aimed at defining new genetic risk factors and tailored interventions for families at hereditary risk for cancers of the breast, ovary, colon, prostate, and lymphoid organs. 

Michelle has over 7 years of experience as clinical genetic counselor and 3 years as a Clinical Director for the Genetic Counseling Graduate Program at LIU Post. As a clinical genetic counselor, she has cared for over 3,000 patients in pediatric, adult, prenatal, cancer and specialty clinics. She has experience in program management, and as the clinical lead genetic counselor for several cancer genetic gastroenterology specialists. She has experience in course development and teaching as an adjunct professor at Long Island University Post and guest lecturing for various local, regional and national conferences. She has mentored several genetic counseling students and undergraduate students in professional development. 

Dr. Ross received her MD and PhD from Cornell University Medical College her Neurology residency at Massachusetts General Hospital and molecular genetic fellowships at MGH and Rockefeller University. She built her laboratory at University of Minnesota before returning to Weill Cornell Medicine as a tenured Professor.  She is a physician scientist who leads the Laboratory of Neurogenetics and Development. Common threads in her work have been discovery of gene mutations causing neurological disorders as a window on the drivers of brain development and function.  The Center for Neurogenetics at WCM that she directs has both basic science and clinical arms, and operates a patient DNA and cell biobank. Dr. Ross has devoted much of her career to medical and neuroscience education. While at the University of Minnesota, she directed the NIH funded MD-PhD training program. At Weill Cornell Medicine she is Chair of the Neuroscience Graduate Program and is the founding Chair of the Master of Science in Genetic Counseling program.

Dr. Devorah Segal earned her MD and PhD in Neuroscience at Icahn Mount Sinai School of Medicine. She completed her pediatrics and pediatric neurology training at Rutgers New Jersey Medical School and then completed a fellowship in Pediatric Neuro-Oncology at NYU Langone Medical Center. She spent several years practicing general child neurology and neurogenetics at Weill Cornell, including helping lead a research neurogenetics clinics.  She is now a pediatric neurologist and neuro-oncologist at NYU Langone, where she is associate director of the Neurofibromatosis Center. She leads several clinical trials treating pediatric brain tumors, neurofibromatosis, and other genetic disorders with neurologic components. 

Dr. Walsh is a pediatric oncologist and clinical geneticist. His work focuses on identifying patients at risk for cancer and utilizing this information for screening, risk reduction and therapeutic purposes. To identify at risk individuals my research agenda entails defining and expanding our understanding of known cancer predisposition syndromes, discovering new cancer predisposition genes as well as helping define means to annotate molecular variations based on scientific rigor. He has been fortunate to train under Victor McKusick, MD, Ada Hamosh, MD, MPH (founders of MIM & OMIM), and James Downing, MD (Pediatric Cancer Genome Project). As a result, he has obtained a unique understanding and skill set related to classical Mendelian genetics and modern genomics relating to tumor- matched normal sequencing. His is now part of an expert Clinical Cancer Genetics team led by Kenneth Offit, MD, MPH and Pediatrics Department directed by Andrew Kung, MD, PhD at Memorial Sloan Kettering (MSK) with a track record in gene discovery, phenotypic description and translational genomic care. Given his training and practice environment, he has a unique opportunity to practice genetics and oncology and aggregate data from these purviews of care. 

Ji-Sun received her Bachelor's and Master's degrees at University of Toronto in Canada, then completed her Master's of Genetic Counseling degree from Sarah Lawrence College. Prior to joining the Weill Cornell Neurogenetics team, she worked as a pediatric genetic counselor at Rutger's University Hospital in New Jersey.